Atlas Trials

Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab

Clinical trial NCT01799798 · COMPLETED

Trial details

NCT number
NCT01799798
Sponsor
University of Cologne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Osteogenesis Imperfecta
Start date
2013-02-01
Primary completion
2015-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.